Quick Answer
Hydroxypinacolone retinoate (HPR) is an ester of retinoic acid that Korean labs pitch as a gentler retinoid. Its human evidence is still thin: most trials test it inside blends, company-affiliated authors appear on every anti-aging trial below, and the closest head-to-head with retinol used a different isomer. In the US, keep its claims to appearance. In Korea, it cannot carry the wrinkle-improvement functional mark on its own.
Say your Korean lab proposes a night serum built on HPR instead of retinol, with a note that reads “gentler retinoid.” Before you approve it, you need two answers. How good is the evidence, and what can the box say?
This guide covers what HPR is, how it compares with retinol, what the published studies actually tested, and where the claim lines sit in the US and Korea.
My first question when a lab pitches HPR is always the same: which study, which form, which dose? Those three answers decide how far your copy can go.
Key Takeaways
- HPR is an ester of retinoic acid, the active form of vitamin A that retinol has to be converted into inside skin.
- Most human studies test HPR inside blends with other actives, and each anti-aging trial below has company-affiliated authors.
- The closest head-to-head with retinol tested a 9-cis isomer, which may not match the HPR on your spec sheet.
- In the US, keep claims to appearance. Collagen and cell-repair wording makes a product a drug.
- In Korea, HPR is not a notified wrinkle-improvement active, so a wrinkle-function claim has to rest on another ingredient.
What Is Hydroxypinacolone Retinoate (HPR)?
Hydroxypinacolone retinoate (HPR) is an ester of retinoic acid, the form of vitamin A that acts on skin cells. PubChem gives its structure as an all-trans retinoate ester of hydroxypinacolone, a small hydroxy ketone, with the formula C26H38O3.
Retinol has to be converted twice inside skin, first to retinal and then to retinoic acid. Our retinol and retinal manufacturing guide walks through that ladder. HPR starts at the acid end of the ladder as an ester, and that chemistry is the root of the gentler-but-effective pitch.
In Korea, the Korea Cosmetic Association’s ingredient dictionary lists HPR under the standard name 하이드록시피나콜론레티노에이트 (code 8151) as a skin-conditioning agent. The same entry shows Granactive Retinoid as a trade-name blend that contains it.
HPR Next to Retinol and Retinyl Palmitate
HPR differs from the two classic vitamin A actives in chemistry and in paperwork. Retinol and retinyl palmitate are notified wrinkle-improvement actives in Korea and are capped in the EU. HPR is neither.
| Point | Retinol | Retinyl palmitate | HPR |
|---|---|---|---|
| What it is | Vitamin A alcohol | Ester of retinol | Ester of retinoic acid |
| Route to retinoic acid | Two conversion steps in skin | Releases retinol first, then two steps | Already an ester of the acid itself |
| Korea notified wrinkle-improvement active | Yes | Yes | No, listed as a skin-conditioning agent |
| EU cap under Regulation 2024/996 | 0.3 percent retinol equivalent (0.05 percent in body lotion) | Same cap, counted as retinol equivalent | Not named in that entry |
| EU “Contains Vitamin A” label line | Required | Required | Not required by that entry |
The EU cap comes from Commission Regulation (EU) 2024/996, which also requires the line “Contains Vitamin A. Consider your daily intake before use.” It covers retinol, retinyl acetate and retinyl palmitate. HPR is not named in that entry.
Not named is not the same as unregulated. An EU product with HPR still needs the product safety assessment that the EU Cosmetics Regulation requires before sale.
How Strong Is the Human Evidence for HPR?
The human evidence for HPR is real but narrow. Most trials test it inside blends with retinol, peptides or vitamin C, and every anti-aging trial below has company-affiliated authors. That makes it hard to credit any single result to HPR alone.
Here is what the main published studies tested, based on their PubMed abstracts.
| Study | Who was tested, for how long | HPR alone or in a blend | Author affiliations |
|---|---|---|---|
| Hu et al., J Invest Dermatol, 2026 | Split-face trial, 31 women, 4 weeks, plus a mouse model | 9-cis HPR at 0.03 percent vs retinol at 0.3 percent | University labs and a company research institute |
| Shen et al., J Cosmet Dermatol, 2026 | Middle-aged women with mild photoaging, 8 weeks | Serum with retinol, HPR, peptides and silybin | A cosmetics company R&D center |
| Fang et al., J Cosmet Dermatol, 2025 | 120 women | Formula with retinyl propionate, HPR and vitamin C | Hospitals and a biotech company |
| Kruger et al., J Cosmet Dermatol, 2024 | 71 women, 16 weeks, serum group vs one laser treatment | Serum with HPR and peptides | A cosmetics company R&D group and a medical practice |
| Wang et al., J Cosmet Dermatol, 2023 | 42 women, 8 weeks | Serum with HPR and retinyl propionate | Hospitals and a company research institute |
| Wu et al., Clin Cosmet Investig Dermatol, 2026 | Mice only, 4 weeks of UVB exposure | HPR alone at three strengths | University hospitals |
Why the 9-cis trial may not describe your HPR
The 2026 JID trial is the closest thing to a head-to-head with retinol, and it reported comparable or better results without observed irritation. But it tested hydroxypinacolone 9-cis retinoate, which the authors describe as a derivative of 9-cis retinoic acid.
The form indexed in PubChem is all-trans. Ask your supplier which form you are buying before your copy leans on that study.
Two more limits apply. The two doses in that trial differ tenfold, so the result says little about the level in your formula. And mouse studies, like the 2026 photoaging work in the table, explain mechanisms but do not count as human evidence.
How to read any HPR study
- Actives: is it the only active, or one of several?
- Form and dose: which isomer, and what percentage of pure HPR rather than of a raw-material blend?
- Design: how many people, for how long, and against what comparison?
- Authors: a university, an ingredient supplier or the brand selling the serum?
“I’m Liz, I run altameet from Manhattan, NYC. When a lab pitches HPR, I ask for the study behind the claim, the form and the dose before anything else. If you want a quick gut-check on an HPR brief, I’ll give you 15 minutes free.”
Stability and Irritation Are Better, Not Solved
HPR held its content better than other retinoids in a stability study of commercial products, and several formulas report low irritation. Neither result replaces your own stability and tolerance tests.
In a 2020 study of 12 commercial retinoid products, researchers tracked retinoid content for six months. Losses ranged from 0 to 80 percent at 25°C and from 40 to 100 percent at 40°C, and light did more damage than heat. Among the retinoids tested, HPR was the most stable.
The same group’s market survey found seven products whose measured retinoid content deviated from the declared amount. Two products contained retinoic acid, which is banned in EU cosmetics. Ask your ODM to assay the active in the finished product, not just to confirm the input amount.
“Gentle” is a test result, not a property of the molecule. In an acne gel study that paired 0.1 percent HPR with retinol, 15.3 percent of 98 patients reported dryness, peeling, redness or burning. A 2025 nanoemulsion study also reported that its carrier reduced irritation from the ingredient in a human patch test.
Encapsulation and packaging are the usual fixes for light and irritation. Plan for opaque or airless packaging, and see our liposome, cyclodextrin and microcapsule guide for carrier options.
What Can a US Brand Claim With HPR?
A US brand can make appearance claims for an HPR product, such as reducing the look of fine lines. Claims that the product changes skin structure or function, such as boosting collagen, make it a drug.
FDA’s page on anti-aging products draws the line by intended use. A product that makes lines less noticeable by moisturizing is a cosmetic. A product intended to affect the structure or function of skin is a drug, even if it also changes appearance.
FDA’s cosmetic-or-drug overview also lists claims to regenerate cells among its examples of drug claims. A gentler retinoid does not change that rule.
| Drug-risk wording | Cosmetic-side alternative |
|---|---|
| Boosts collagen production | Skin looks firmer and smoother |
| Repairs or regenerates skin cells | Improves the look of skin texture |
| Erases wrinkles | Reduces the look of fine lines |
| Works like a prescription retinoid | A retinoid serum for nightly use |
Appearance claims still need support. Our HRIPT vs clinical vs consumer testing guide explains which test backs which claim, and our FDA requirements guide for Korean skincare covers the rest of the US rule set.
Can a Korean HPR Product Carry the Wrinkle-Improvement Mark?
Not on the strength of HPR alone. Korea’s notified wrinkle-improvement actives are retinol, retinyl palmitate, adenosine and polyethoxylated retinamide, and HPR is not one of them.
The Korea Cosmetic Association dictionary flags retinol, retinyl palmitate and polyethoxylated retinamide as functional cosmetic ingredients, and it lists adenosine under wrinkle improvement. The HPR entry carries no such flag.
So if a Korean HPR sample carries the wrinkle-improvement functional mark, ask which notified active is behind it and at what level. Our adenosine sourcing guide covers one of those notified routes.
The HPR Brief to Send Your Korean ODM
A short brief prevents most rework. State the form, the pure HPR percentage, any other retinoids, the packaging, the tests and the claims before the first sample is made.
- Form and spec. All-trans or 9-cis HPR, with the supplier’s specification sheet and certificate of analysis.
- Pure HPR content. Some HPR materials are trade-name blends, so confirm whether the formula percentage refers to the blend or to the active itself.
- Other retinoids. If HPR joins retinol or a retinyl ester, list each level separately.
- Assay. The active measured in the finished product at release and at each stability pull.
- Light protection. Opaque or airless packaging, plus a photostability check.
- Tolerance testing. A patch test and an in-use test matched to any “gentle” or sensitive-skin claim.
- Claims list. US appearance wording and, for Korea, the notified active behind any functional mark.
Pregnancy positioning is its own topic, and our pregnancy-safe formulation guide covers how Korean ODMs handle retinoid swaps. If your brief also calls for a calming botanical, our heartleaf ingredient guide covers one Korean option.
HPR Formula Brief Checklist
Get the full checklist as a free PDF, straight to your inbox.
Frequently Asked Questions
Is HPR the same as Granactive Retinoid?
Not exactly. Granactive Retinoid is a trade name that the Korean ingredient dictionary lists as a blend containing HPR. Ask the supplier how much of it the blend contains, and spec the pure level in your formula.
Can HPR and retinol go in the same serum?
Yes. Several published formulas combine them, including a 2026 serum with retinol, HPR, peptides and silybin. Two retinoids add irritation potential, so set each level and run an in-use test before you call the product gentle.
How long did HPR studies run before reporting results?
The human trials in this guide that state a duration ran from four to sixteen weeks. A timing claim such as visible results in four weeks needs your own finished-product test.
Does an HPR product need the EU vitamin A warning?
Not under Regulation (EU) 2024/996 alone, because its warning line covers retinol, retinyl acetate and retinyl palmitate. If your formula also contains one of those three, the warning line and the cap apply.
By Liz Song, K-beauty sourcing consultant.
